| Dr Rebekah Allen, DO | |
|
2345 Dougherty Ferry Road, St. Louis, MO 63122 | |
| (314) 966-9100 | |
| Not Available |
| Full Name | Dr Rebekah Allen |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 2345 Dougherty Ferry Road, St. Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710263033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2011031864 (Missouri) | Secondary |
| 208M00000X | Hospitalist | 2014036407 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm St Clare Health Center | Fenton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galen Inpatient Physicians Pc | 3678464633 | 345 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Dr. Petre I Anguelinin, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265538177 PECOS PAC ID: 4981602927 Enrollment ID: O20070102000375 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Cogent Healthcare Of Missouri Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780961599 PECOS PAC ID: 5597925099 Enrollment ID: O20120320000863 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20160809000235 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Sound Physicians Of Illinois Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043598865 PECOS PAC ID: 1557533734 Enrollment ID: O20170519000666 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of Missouri - Bridgeton, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275012452 PECOS PAC ID: 2567713571 Enrollment ID: O20181001001537 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Entity Name | Galen Inpatient Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538714688 PECOS PAC ID: 3678464633 Enrollment ID: O20191115000362 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebekah Allen, DO 2345 Dougherty Ferry Road, St. Louis, MO 63122 Ph: () - | Dr Rebekah Allen, DO 2345 Dougherty Ferry Road, St. Louis, MO 63122 Ph: (314) 966-9100 |
News Archive
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.
GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.
Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.
› Verified 6 days ago
Dr. Sai Prashanth Babu Palepu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10018 Kennerly Rd., St. Louis, MO 63128 Phone: 314-208-6000 | |
Dr. Fadee Abu Al Rub, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Center For Specialized Medicine, 1225 S Grand Blvd., St. Louis, MO 63104 Phone: 314-257-3760 | |
Dr. David Andrew Wathen, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-577-1607 Fax: 314-268-4112 | |
Dr. Manny Chekol Zewdu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1402 S. Grand, Fdt 14th Floor, St. Louis, MO 63104 Phone: 314-577-8762 |